BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36138418)

  • 1. CD3Ɛ immune restorative ability induced by Maitake Pro4x in immunosupressed BALBc mice.
    Aguilera-Braico DM; Balogh GA
    BMC Res Notes; 2022 Sep; 15(1):307. PubMed ID: 36138418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maitake Pro4X has anti-cancer activity and prevents oncogenesis in BALBc mice.
    Roldan-Deamicis A; Alonso E; Brie B; Braico DA; Balogh GA
    Cancer Med; 2016 Sep; 5(9):2427-41. PubMed ID: 27401257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble β-glucan from Grifola frondosa induces tumor regression in synergy with TLR9 agonist via dendritic cell-mediated immunity.
    Masuda Y; Nawa D; Nakayama Y; Konishi M; Nanba H
    J Leukoc Biol; 2015 Dec; 98(6):1015-25. PubMed ID: 26297795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Maitake (Grifola frondosa) D-Fraction on the activation of NK cells in cancer patients.
    Kodama N; Komuta K; Nanba H
    J Med Food; 2003; 6(4):371-7. PubMed ID: 14977447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maitake beta-glucan MD-fraction enhances bone marrow colony formation and reduces doxorubicin toxicity in vitro.
    Lin H; She YH; Cassileth BR; Sirotnak F; Cunningham Rundles S
    Int Immunopharmacol; 2004 Jan; 4(1):91-9. PubMed ID: 14975363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of orally administered maitake α-glucan by stimulating antitumor immune response in murine tumor.
    Masuda Y; Nakayama Y; Tanaka A; Naito K; Konishi M
    PLoS One; 2017; 12(3):e0173621. PubMed ID: 28278221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genes related to suppression of malignant phenotype induced by Maitake D-Fraction in breast cancer cells.
    Alonso EN; Orozco M; Eloy Nieto A; Balogh GA
    J Med Food; 2013 Jul; 16(7):602-17. PubMed ID: 23875900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maitake extracts and their therapeutic potential.
    Mayell M
    Altern Med Rev; 2001 Feb; 6(1):48-60. PubMed ID: 11207456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Cross-Flow Ultrafiltration Fractions from Maitake Medicinal Mushroom, Grifoia frondosa (Agaricomycetes), Reveals Distinct Cytotoxicity in Tumor Cells.
    Sari M; Hambitzer R; Lelley JI; Toepler K; Teusch N; Nickisch-Hartfiel A
    Int J Med Mushrooms; 2016; 18(8):671-680. PubMed ID: 27910785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maitake beta-glucan enhances granulopoiesis and mobilization of granulocytes by increasing G-CSF production and modulating CXCR4/SDF-1 expression.
    Ito K; Masuda Y; Yamasaki Y; Yokota Y; Nanba H
    Int Immunopharmacol; 2009 Sep; 9(10):1189-96. PubMed ID: 19573626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral administration of soluble β-glucans extracted from Grifola frondosa induces systemic antitumor immune response and decreases immunosuppression in tumor-bearing mice.
    Masuda Y; Inoue H; Ohta H; Miyake A; Konishi M; Nanba H
    Int J Cancer; 2013 Jul; 133(1):108-19. PubMed ID: 23280601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumoral Effects of D-Fraction from Grifola Frondosa (Maitake) Mushroom in Breast Cancer.
    Alonso EN; Ferronato MJ; Gandini NA; Fermento ME; Obiol DJ; López Romero A; Arévalo J; Villegas ME; Facchinetti MM; Curino AC
    Nutr Cancer; 2017 Jan; 69(1):29-43. PubMed ID: 27892708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maitake beta-glucan enhances umbilical cord blood stem cell transplantation in the NOD/SCID mouse.
    Lin H; De Stanchina E; Zhou XK; She Y; Hoang D; Cheung SW; Cassileth B; Cunningham-Rundles S
    Exp Biol Med (Maywood); 2009 Mar; 234(3):342-53. PubMed ID: 19144872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maitake mushroom (Grifola frondosa): systematic review by the natural standard research collaboration.
    Ulbricht C; Weissner W; Basch E; Giese N; Hammerness P; Rusie-Seamon E; Varghese M; Woods J
    J Soc Integr Oncol; 2009; 7(2):66-72. PubMed ID: 19476741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maturation of dendritic cells by maitake α-glucan enhances anti-cancer effect of dendritic cell vaccination.
    Masuda Y; Nakayama Y; Mukae T; Tanaka A; Naito K; Konishi M
    Int Immunopharmacol; 2019 Feb; 67():408-416. PubMed ID: 30586664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of maitake (Grifola frondosa) polysaccharide on collagen-induced arthritis in mice.
    Shigesue K; Kodama N; Nanba H
    Jpn J Pharmacol; 2000 Nov; 84(3):293-300. PubMed ID: 11138730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maitake beta-glucan enhances therapeutic effect and reduces myelosupression and nephrotoxicity of cisplatin in mice.
    Masuda Y; Inoue M; Miyata A; Mizuno S; Nanba H
    Int Immunopharmacol; 2009 May; 9(5):620-6. PubMed ID: 19249389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential growth inhibitory effect of maitake D-fraction on canine cancer cells.
    Konno S
    Vet Ther; 2004; 5(4):263-71. PubMed ID: 15719326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can maitake MD-fraction aid cancer patients?
    Kodama N; Komuta K; Nanba H
    Altern Med Rev; 2002 Jun; 7(3):236-9. PubMed ID: 12126464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. beta-(1-->3, 1-->4) oat glucan enhances resistance to Eimeria vermiformis infection in immunosuppressed mice.
    Yun CH; Estrada A; Van Kessel A; Gajadhar AA; Redmond MJ; Laarveld B
    Int J Parasitol; 1997 Mar; 27(3):329-37. PubMed ID: 9138036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.